Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine
Titel:
Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine
Auteur:
Grob, J.-J. Amonkar, M.M. Martin-Algarra, S. Demidov, L.V. Goodman, V. Grotzinger, K. Haney, P. Kämpgen, E. Karaszewska, B. Mauch, C. Miller Jr, W.H. Millward, M. Mirakhur, B. Rutkowski, P. Chiarion-Sileni, V. Swann, S. Hauschild, A.